![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Genentech, a member of the Roche Group , announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma for whom surgery is considered inappropriate.
|
| Thread Tools | |
| Display Modes | |
|
|